ProSciento Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ProSciento Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10601
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProSciento Inc (ProSciento), formerly Profil Institute for Clinical Research Inc is contract research organization that develops drugs and devices for the treatment of obesity, diabetes and metabolic diseases. The organization offers services such as clinical development and regulatory services, early phase clinical research of metabolic drugs and devices, data management and statistical services, site selection, management and monitoring services, continuous risk contingency assessments and others. It develops products through clinical trial management platform integrating multi-site trial design, biomarker selection, patient enrichment and pre-screening strategies, NASH methodologies and trial logistics management. The organization caters to various CROs, pharmaceutical and medical device companies. ProSciento is headquartered in Chula Vista, California, the US.

ProSciento Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ProSciento Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ProSciento Inc, Medical Devices Deals, 2012 to YTD 2018 9
ProSciento Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ProSciento Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Profil Institute for Clinical Research Enters into partnership with Shenzhen HighTide Biopharmaceutical 11
Profil Institute for Clinical Research Enters into Agreement with LMC Diabetes & Endocrinology 12
Profil Institute for Clinical Research Enters into Agreement with Gubra 13
Profil Institute For Clinical Research And Mercodia Enter Into Partnership 14
Profil Institute for Clinical Research Enters Into Joint Venture Agreement With Florida Hospital 15
ProSciento Inc – Key Competitors 16
ProSciento Inc – Key Employees 17
ProSciento Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Aug 06, 2018: ProSciento Expands Executive Team, Appoints Brian Mooney Chief Operating Officer 19
Jun 19, 2018: ProSciento Names Dr. Carine Beysen To Senior Scientific Team 20
May 30, 2017: ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors 21
Other Significant Developments 22
Mar 07, 2018: ProSciento Expands Asia Pacific Operations with Office in Australia 22
Jan 10, 2017: Profil Institute for Clinical Research Announces Corporate Name Change to ProSciento to Reflect Expanded Metabolism-Focused Clinical R&D Services 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
ProSciento Inc, Pharmaceuticals & Healthcare, Key Facts 2
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ProSciento Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ProSciento Inc, Deals By Therapy Area, 2012 to YTD 2018 8
ProSciento Inc, Medical Devices Deals, 2012 to YTD 2018 9
ProSciento Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Profil Institute for Clinical Research Enters into partnership with Shenzhen HighTide Biopharmaceutical 11
Profil Institute for Clinical Research Enters into Agreement with LMC Diabetes & Endocrinology 12
Profil Institute for Clinical Research Enters into Agreement with Gubra 13
Profil Institute For Clinical Research And Mercodia Enter Into Partnership 14
Profil Institute for Clinical Research Enters Into Joint Venture Agreement With Florida Hospital 15
ProSciento Inc, Key Competitors 16
ProSciento Inc, Key Employees 17

List of Figures
ProSciento Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ProSciento Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ProSciento Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ProSciento Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ProSciento Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of several cancers including non-small cell lung cancer and pancreatic cancer. It …
  • Nordion (Canada) Inc:企業の戦略的SWOT分析
    Nordion (Canada) Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • NanoString Technologies Inc (NSTG)-医療機器分野:企業M&A・提携分析
    Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, ge …
  • Energy Transfer Equity, L.P.:企業のM&A・事業提携・投資動向
    Energy Transfer Equity, L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Energy Transfer Equity, L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Slavneft-Megionneftegaz (MFGS):企業の財務・戦略的SWOT分析
    Summary Slavneft-Megionneftegaz (Megionneftegaz), a subsidiary of Slavneft, is an oil and gas company that operates oil fields. The company’s activities include appraisal of oil and gas fields, oil and gas production, and well drilling and operation. Megionneftegaz develops and introduces advanced t …
  • Dayton Superior Corporation:企業の戦略的SWOT分析
    Dayton Superior Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Color Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Color Genomics, Inc. (Color) provides physician ordered genetic testing service that helps to identify hereditary cancer risk. The company’s clinical grade test provides actionable results that enable consumers and their doctors to create personalized screening and healthcare plan. Color ana …
  • Elephant Oil Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Elephant Oil Ltd (Elephant Oil) is an oil and gas company. The company provides services such as exploration and production of oil and natural gas. It provides its exploration services in the underexplored areas of West Africa. Elephant Oil holds interest in a production-sharing contract in …
  • Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析
    Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • IC Group A/S:企業の戦略・SWOT・財務情報
    IC Group A/S - Strategy, SWOT and Corporate Finance Report Summary IC Group A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Baoye Group Company Limited:企業の戦略・SWOT・財務情報
    Baoye Group Company Limited - Strategy, SWOT and Corporate Finance Report Summary Baoye Group Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Expanesthetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Expanesthetics Inc (Expanesthetics) is a developer of anesthetic and analgesic agents. The company develops inhalation anesthetic agents used in surgical procedures. It offers CNS drug development programs for various types of pains and indications such as post-operative pain, traumatic inju …
  • KCA Deutag Alpha Ltd:企業の戦略的SWOT分析
    KCA Deutag Alpha Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • API Group plc:企業の戦略・SWOT・財務情報
    API Group plc - Strategy, SWOT and Corporate Finance Report Summary API Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Azul SA (AZUL4):企業の財務・戦略的SWOT分析
    Azul SA (AZUL4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Merus NV (MRUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Merus NV (Merus) is a clinical-stage immuno-oncology company that discovers and develops human bispecific antibody therapeutics for the treatment of cancer. The company’s pipeline antibody candidates are intended for the treatment of breast cancer, ovarian cancer, colorectal cancer, acute my …
  • Taylor Wessing Llp:企業の戦略・SWOT・財務分析
    Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report Summary Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Santen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Santen Inc (Santen), a subsidiary of Santen Pharmaceutical Co Ltd is a developer, manufacturer and distributor of ophthalmic pharmaceutical products. The company offers products in therapeutic areas such as retinal disorders, glaucoma and corneal diseases. It conducts diagnosis on uveitis co …
  • Guangdong Biolight Meditech Co Ltd (300246):医療機器:M&Aディール及び事業提携情報
    Summary Guangdong Biolight Meditech Co Ltd (Biolight) is a medical device company. The company operates in the business of research, development, production and sale of medical treatment monitors, medical consumables and healthcare solutions. It offers patient monitors, hemodialysis products and hom …
  • Haier Group:企業の戦略・SWOT・財務情報
    Haier Group - Strategy, SWOT and Corporate Finance Report Summary Haier Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆